SEC 13F Intelligence

Managers / Q4 2018 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$132M
Q4 2018
Positions
209
Filings on Record
30
2019–present window
Filed
Feb 15, 2019
original filing

Summary

Worth Venture Partners, LLC reported $132M in U.S.-listed holdings across 209 positions for Q4 2018.

Its largest position, Molina Healthcare, represents 19.6% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+64.8%
share of reported value
Largest Position
+19.6%
Molina Healthcare

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 61.4%Common Stock: 16.2%ETP: 9.2%GLOBAL: 7.8%Other: 5.4%
  • US DOMESTIC · 61.4% · $81M
  • Common Stock · 16.2% · $21M
  • ETP · 9.2% · $12M
  • GLOBAL · 7.8% · $10M
  • Other · 5.4% · $7M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
MOLINA HEALTHCARE INCNEW+9.13M9.13M+$26M$26M
ADVANCED MICRO DEVICES INCNEW+4.82M4.82M+$12M$12M
CAESARS ENTMT CORPNEW+8.29M8.29M+$10M$10M
NEUROCRINE BIOSCIENCES INCNEW+7.09M7.09M+$8M$8M
SQUARE INCNEW+3.21M3.21M+$8M$8M
CLEVELAND CLIFFS INCNEW+4.59M4.59M+$5M$5M
INTERCEPT PHARMACEUTICALS INNEW+5.32M5.32M+$5M$5M
QCOMQUALCOMM INCNEW+67.4K67.4K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2018

68 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MOLINA HEALTHCARE INCNOTE 1.125% 1/119.59%$26M9.13M
2ADVANCED MICRO DEVICES INCNOTE 2.125% 9/08.81%$12M4.82M
3CAESARS ENTMT CORPNOTE 5.000%10/07.81%$10M8.29M
4NEUROCRINE BIOSCIENCES INCNOTE 2.250% 5/16.37%$8M7.09M
5SQUARE INCNOTE 0.375% 3/05.94%$8M3.21M
6CLEVELAND CLIFFS INCDBCV 1.500% 1/13.79%$5M4.59M
7INTERCEPT PHARMACEUTICALS INNOTE 3.250% 7/03.78%$5M5.32M
8XLVSELECT SECTOR SPDR TRSBI HEALTHCARE · SBI CONS DISCR · SBI INT-INDS · SBI INT-FINL · SBI CONS STPLS · COMMUNICATION · SBI INT-UTILS · RL EST SEL SEC · ENERGY3.15%$4M71.2K
9QCOMQUALCOMM INChistory →COM2.90%$4M67.4K
10MEDICINES CONOTE 2.500% 1/12.63%$3M4.08M
11WRIGHT MED GROUP N VNOTE 2.250%11/12.60%$3M2.50M
12SPSBSPDR SERIES TRUSTPORTFOLIO SHORT · S&P BIOTECH · S&P PHARMAC2.42%$3M93.5K
13IWMISHARES TRhistory →RUSSELL 2000 ETF · RUSSELL 2000 ETF - looks right2.13%$3M21.0K
14Yahoo IncNote1.98%$3M2.29M
15INSMED INCNOTE 1.750% 1/11.50%$2M2.79M
16AMSCAMERICAN SUPERCONDUCTOR CORPhistory →SHS NEW1.42%$2M168.0K
17REALPAGE INCCOM1.32%$2M1.36M
18WEATHERFORD INTL LTDNOTE 5.875% 7/0 · ORD SHS1.23%$2M2.43M
19AIRGAIRGAIN INChistory →COM1.09%$1M145.1K
20ACORDA THERAPEUTICS INCNOTE 1.750% 6/10.99%$1M1.56M
21HORIZON PHARMA PLCNOTE 2.500% 3/10.87%$1M1.16M
22CALXCALIX INCCOM0.84%$1M114.0K
23XILINX INCCOM0.84%$1M13.0K
24VCSHVANGUARD SCOTTSDALE FDSSHRT TRM CORP BD0.77%$1M13.0K
25VUZIVUZIX CORPCOM NEW0.73%$961,000200.0K
26VGTVANGUARD WORLD FDSINF TECH ETF0.71%$933,0005.6K
27BMRNBIOMARIN PHARMACEUTICAL INCCOM · NOTE 1.500%10/10.67%$886,00010.4K
28QUANTENNA COMMUNICATIONS INCCOM0.57%$754,00052.6K
29BIODELIVERY SCIENCES INTL INCOM0.57%$754,000204.3K
30LITELUMENTUM HLDGS INCCOM0.57%$754,00017.9K
31KEMET CORPCOM0.56%$735,00042.0K
32MXMAGNACHIP SEMICONDUCTOR SACOM0.52%$690,000111.3K
33APPSDIGITAL TURBINE INCCOM NEW0.51%$678,000370.6K
34PIXELWORKS INCCOM NEW0.44%$585,000201.8K
35PBYIPUMA BIOTECHNOLOGY INCCOM0.43%$565,00027.8K
36ATTUNITY LTDSHS NEW0.42%$560,00028.5K
37KNKNOWLES CORPCOM0.33%$437,00032.8K
38QUICKLOGIC CORPCOM0.33%$434,000592.8K
39BIONANO GENOMICS INCCOM0.32%$417,00079.9K
40LTRXLANTRONIX INCCOM NEW0.31%$414,000142.5K
41CLFDCLEARFIELD INCCOM0.31%$413,00041.6K
42SMTCSEMTECH CORPCOM0.30%$394,0008.6K
43ALLOT COMMUNICATIONS LTDSHS0.30%$390,00064.4K
44DMACDIAMEDICA THERAPEUTICS INCCOM NEW0.29%$377,000129.9K
45APOLLO ENDOSURGERY INCCOM0.28%$368,000107.0K
46DSP GROUP INCCOM0.27%$351,00031.4K
47QUANTUM CORPCOM NEW0.25%$336,000168.5K
48PROGENICS PHARMACEUTICALS INCOM0.24%$318,00076.2K
49WESTPORT FUEL SYSTEMS INCCOM NEW0.20%$265,000200.0K
50NEOSNEOS THERAPEUTICS INCCOM0.19%$248,000150.6K
51OSSONE STOP SYS INCCOM0.18%$232,000120.0K
52MILLENDO THERAPEUTICS INCCOM0.16%$206,00026.0K
53RIGEL PHARMACEUTICALS INCCOM NEW0.15%$200,00087.4K
54AGXARGAN INCCOM0.15%$197,0005.2K
55VIVUS INCNOTE 4.500% 5/00.08%$111,00050.3K
56ACHIEVE LIFE SCIENCE INCCOM NEW0.08%$108,00089.6K
57AXSMAXSOME THERAPEUTICS INCCOM0.07%$96,00034.4K
58NANOVIBRONIX INCCOM0.05%$72,00020.0K
59ENTERA BIO LTDSHS0.04%$53,00026.9K
60FOAMIX PHARMACEUTICALS LTDSHS0.04%$48,00013.5K
61IECIEC ELECTRS CORP NEWCOM0.04%$48,0008.8K
62PDVWIRELESS INCCOM0.03%$42,0001.1K
63WIRELESS TELECOM GROUP INCCOM0.02%$32,00018.1K
64ACTINIUM PHARMACEUTICALS INCCOM0.02%$22,00059.1K
65SANOFIRIGHT 12/31/20200.01%$12,00027.0K
66APHRIA INCCOM0.01%$12,0002.3K
67PAIN THERAPEUTICS INCCOM NEW0.00%$6,0008.2K
68SPYSPDR S&P 500 ETF TRTR UNIT0.00%$01

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • DLD Asset Management, LP028-17749
  • PCJ Investment Counsel Ltd.028-12690

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.